Meta-analysis of the relevance of the <ce:italic>OPRM1</ce:italic> 118A>G genetic variant for pain treatment

@article{Walter2009MetaanalysisOT,
  title={Meta-analysis of the relevance of the <ce:italic>OPRM1</ce:italic> 118A>G genetic variant for pain treatment},
  author={Carmen Walter and J{\"o}rn L{\"o}tsch},
  journal={PAIN},
  year={2009},
  volume={146},
  pages={270-275}
}
Regard of functional pharmacogenetic polymorphisms may further the success of pain therapy by adopting individualized approaches. The mu-opioid receptor gene (OPRM1) 118A>G polymorphism is a promising candidate for both opioid effects and pain because of both biological reasonability and apparent experimental and clinical evidence. We analyzed its importance for pain therapy using a meta-analytic approach to studies relating it to opioid pain therapy. Data from suitable studies selected from… CONTINUE READING
Highly Cited
This paper has 128 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

Drug Testing and Toxicology: Redefining the Plague of Darkness.

Clinics in laboratory medicine • 2016
View 1 Excerpt

129 Citations

0102030'11'13'15'17'19
Citations per Year
Semantic Scholar estimates that this publication has 129 citations based on the available data.

See our FAQ for additional information.